A previous study found that populations in Qujing with advanced NSCLC had a distinct mutational spectrum (higher EGFR G719X+S768I, EGFR G719X+L861Q and KRAS) compared with patients in other parts of Yunnan Province. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.